The Hormonal Tug-of-War: Estrogen-Only Therapy and the Risk of Autoimmune Disease
By Rachael Robertson, Enterprise & Investigative Writer October 23, 2026 The intricate relationship between sex hormones and the human immune system has long been a subject of intense scientific scrutiny.…
New Research Flags Potential Cardiovascular Risks of Testosterone Therapy in Menopause
By Rachael Robertson, Enterprise & Investigative Writer October 21, 2026 The use of testosterone therapy to manage the complex symptoms of menopause has long been a subject of clinical debate.…
Beyond the Mind: Psilocybin Therapy Shows Promise in Reducing Biological Markers of Parkinson’s Disease
By Judy George, Deputy Managing Editor, MedPage Today October 21, 2026 In a pioneering exploration of psychedelic medicine, researchers have uncovered evidence that psilocybin therapy—typically associated with mental health treatment—may…
Renal Replacement Therapy in the ICU: New ICRAKI Trial Challenges Standard Approaches to Acute Kidney Injury
October 14, 2026 — In a significant shift for critical care medicine, findings from the randomized ICRAKI trial, published in the New England Journal of Medicine, have reignited a long-standing…
Cardiac Microcurrent Therapy: A "Too Good to Be True" Breakthrough in Heart Failure Treatment?
By Nicole Lou, Senior Staff Writer, MedPage Today October 13, 2026 In the rapidly evolving landscape of heart failure (HF) management, few emerging technologies have generated as much curiosity—and healthy…
Beyond the Stroke: Rethinking Neurological Risks in Modern LVAD Therapy
For decades, the primary concern surrounding Left Ventricular Assist Devices (LVADs) has been the specter of stroke. As mechanical circulatory support has evolved from primitive pumps to the sophisticated, magnetically…















